Literature DB >> 17579058

Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization.

Giuseppe Terrazzano1, Michela Sica, Carmen Gianfrani, Giuseppe Mazzarella, Francesco Maurano, Beatrice De Giulio, Sophie de Saint-Mezard, Delia Zanzi, Luigi Maiuri, Marco Londei, Bana Jabri, Riccardo Troncone, Salvatore Auricchio, Serafino Zappacosta, Ennio Carbone.   

Abstract

We analyzed the autologous NK cell interaction with gliadin-presenting dendritic cells. Gliadin is the known Ag priming the celiac disease (CD) pathogenesis. We demonstrate that gliadin prevents immature dendritic cells (iDCs) elimination by NK cells. Furthermore, cooperation between human NK cells-iDCs and T cells increases IFN-gamma production of anti-gliadin immune response. Gliadin fractions were analyzed for their capability to stabilize HLA-E molecules. The alpha and omega fractions conferred the protection from NK cell lysis to iDCs and increased their HLA-E expression. Gliadin pancreatic enzyme digest and a peptide derived from gliadin alpha increased HLA-E levels on murine RMA-S/HLA-E-transfected cells. Analysis of HLA-E expression in the small intestinal mucosa of gluten-containing diet celiac patients and organ culture experiments confirmed the in vitro data.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17579058     DOI: 10.4049/jimmunol.179.1.372

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

Review 1.  Intraepithelial lymphocytes in celiac disease immunopathology.

Authors:  Valérie Abadie; Valentina Discepolo; Bana Jabri
Journal:  Semin Immunopathol       Date:  2012-06-03       Impact factor: 9.623

Review 2.  Dendritic cells in intestinal homeostasis and disease.

Authors:  Maria Rescigno; Antonio Di Sabatino
Journal:  J Clin Invest       Date:  2009-09-01       Impact factor: 14.808

Review 3.  Tissue-mediated control of immunopathology in coeliac disease.

Authors:  Bana Jabri; Ludvig M Sollid
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

Review 4.  Triggers and drivers of autoimmunity: lessons from coeliac disease.

Authors:  Ludvig M Sollid; Bana Jabri
Journal:  Nat Rev Immunol       Date:  2013-03-15       Impact factor: 53.106

Review 5.  The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.

Authors:  Gabriella Pietra; Chiara Romagnani; Claudia Manzini; Lorenzo Moretta; Maria Cristina Mingari
Journal:  J Biomed Biotechnol       Date:  2010-06-22

6.  Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis.

Authors:  Giuseppe Mazzarella; Rosita Stefanile; Alessandra Camarca; Paolo Giliberti; Elena Cosentini; Caterina Marano; Gaetano Iaquinto; Nicola Giardullo; Salvatore Auricchio; Alessandro Sette; Riccardo Troncone; Carmen Gianfrani
Journal:  Gastroenterology       Date:  2008-01-11       Impact factor: 22.682

7.  NK cells blur the frontier between innate and acquired immunity.

Authors:  Giuseppe Terrazzano; Ennio Carbone
Journal:  Front Immunol       Date:  2013-01-02       Impact factor: 7.561

8.  Bifidobacterium longum CECT 7347 modulates immune responses in a gliadin-induced enteropathy animal model.

Authors:  José Moisés Laparra; Marta Olivares; Onofrio Gallina; Yolanda Sanz
Journal:  PLoS One       Date:  2012-02-10       Impact factor: 3.240

Review 9.  Interplay Between Gluten, HLA, Innate and Adaptive Immunity Orchestrates the Development of Coeliac Disease.

Authors:  Jordan Voisine; Valérie Abadie
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

10.  CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.

Authors:  Emma J Petrie; Craig S Clements; Jie Lin; Lucy C Sullivan; Darryl Johnson; Trevor Huyton; Annie Heroux; Hilary L Hoare; Travis Beddoe; Hugh H Reid; Matthew C J Wilce; Andrew G Brooks; Jamie Rossjohn
Journal:  J Exp Med       Date:  2008-03-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.